Hepatitis C Virus Blocks Interferon Effector Function by Inducing Protein Kinase R Phosphorylation

被引:206
作者
Garaigorta, Urtzi [1 ]
Chisari, Francis V. [1 ]
机构
[1] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA
基金
美国国家卫生研究院;
关键词
CONSENSUS INTERFERON; PLUS RIBAVIRIN; INITIAL TREATMENT; ANTIVIRAL ACTIONS; RNA; RESISTANCE; PKR; REPLICATION; INFECTION; DETERMINANTS;
D O I
10.1016/j.chom.2009.11.004
中图分类号
Q93 [微生物学];
学科分类号
071005 [微生物学];
摘要
Hepatitis C virus (HCV) is a single-stranded RNA virus encoding a single polyprotein whose translation is driven by an internal ribosome entry site (IRES). HCV infection strongly induces antiviral interferon-stimulated gene (ISG) expression in the liver, yet it persists, suggesting that HCV can block ISG effector function. We now show that HCV infection triggers phosphorylation and activation of the RNA-dependent protein kinase PKR, which inhibits eukaryotic translation initiation factor elF2 alpha and attenuates ISG protein expression despite normal ISG mRNA induction. ISG protein induction is restored and the antiviral effects of interferon are enhanced when PKR expression is suppressed in interferon-treated infected cells. Whereas host protein translation, including antiviral ISGs, is suppressed by activated PKR, HCV IRES-dependent translation is not. These results suggest that the ability of HCV to activate PKR may, paradoxically, be advantageous for the virus during an IFN response by preferentially suppressing the translation of ISGs.
引用
收藏
页码:513 / 522
页数:10
相关论文
共 48 条
[1]
Recovery, persistence, and sequelae in hepatitis C virus infection: A perspective on long-term outcome [J].
Alter, HJ ;
Seeff, LB .
SEMINARS IN LIVER DISEASE, 2000, 20 (01) :17-35
[2]
Activation of Rho-associated coiled-coil protein kinase 1 (ROCK-1) by caspase-3 cleavage plays an essential role in cardiac myocyte apoptosis [J].
Chang, Jiang ;
Xie, Min ;
Shah, Viraj R. ;
Schneider, Michael D. ;
Entman, Mark L. ;
Wei, Lei ;
Schwartz, Robert J. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (39) :14495-14500
[3]
GENETIC ORGANIZATION AND DIVERSITY OF THE HEPATITIS-C VIRUS [J].
CHOO, QL ;
RICHMAN, KH ;
HAN, JH ;
BERGER, K ;
LEE, C ;
DONG, C ;
GALLEGOS, C ;
COIT, D ;
MEDINASELBY, A ;
BARR, PJ ;
WEINER, AJ ;
BRADLEY, DW ;
KUO, G ;
HOUGHTON, M .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (06) :2451-2455
[4]
Old and emerging therapies in chronic hepatitis C: an update [J].
Deutsch, M. ;
Hadziyannis, S. J. .
JOURNAL OF VIRAL HEPATITIS, 2008, 15 (01) :2-11
[5]
The exchangeable apolipoprotein ApoC-I promotes membrane fusion of hepatitis C virus [J].
Dreux, Marlene ;
Boson, Bertrand ;
Ricard-Blum, Sylvie ;
Molle, Jennifer ;
Lavillette, Dimitri ;
Bartosch, Birke ;
Pecheur, Eve-Isabelle ;
Cosset, Francois-Loic .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2007, 282 (44) :32357-32369
[6]
Erickson AK, 2008, ANTIVIR THER, V13, P851
[7]
Control of antiviral defenses through hepatitis C virus disruption of retinoic acid-inducible gene-I signaling [J].
Foy, E ;
Li, K ;
Sumpter, R ;
Loo, YM ;
Johnson, CL ;
Wang, CF ;
Fish, PM ;
Yoneyama, M ;
Fujita, T ;
Lemon, SM ;
Gale, M .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (08) :2986-2991
[8]
Kissing-loop interaction in the 3′ end of the hepatitis C virus genome essential for RNA replication [J].
Friebe, P ;
Boudet, J ;
Simorre, JP ;
Bartenschlager, R .
JOURNAL OF VIROLOGY, 2005, 79 (01) :380-392
[9]
Sequences in the 5′ nontranslated region of hepatitis C virus required for RNA replication [J].
Friebe, P ;
Lohmann, V ;
Krieger, N ;
Bartenschlager, R .
JOURNAL OF VIROLOGY, 2001, 75 (24) :12047-12057
[10]
Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. [J].
Fried, MW ;
Shiffman, ML ;
Reddy, KR ;
Smith, C ;
Marinos, G ;
Goncales, FL ;
Haussinger, D ;
Diago, M ;
Carosi, G ;
Dhumeaux, D ;
Craxi, A ;
Lin, A ;
Hoffman, J ;
Yu, J .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (13) :975-982